SDC1(Syndecan-1)是一种跨膜蛋白多糖,属于Syndecan基因家族(包含SDC1-4四个成员),该家族共性是通过其核心蛋白与硫酸乙酰肝素(Heparan Sulfate, HS)链结合,参与细胞间黏附、信号传导及微环境调控。SDC1主要表达于上皮细胞和浆细胞表面,其生物学功能包括:1)作为共受体协助生长因子(如FGF、HGF)与受体结合,激活下游促增殖或分化通路;2)通过HS链结合细胞外基质成分(如纤连蛋白、胶原)维持组织结构;3)调控炎症反应,例如通过结合趋化因子引导免疫细胞迁移。SDC1的突变可能导致其胞外域脱落(shedding)异常,与多发性骨髓瘤(浆细胞中SDC1高表达且脱落片段促进肿瘤进展)、乳腺癌(突变后失去抑癌功能)等疾病相关。过表达SDC1会增强肿瘤细胞转移能力(因HS链促进侵袭),而敲低表达则削弱伤口愈合(因生长因子信号受阻)。该基因还参与Wnt/β-catenin等通路,过表达可能抑制PTEN等抑癌基因。其可溶性形式(sSDC1)是炎症标志物,在COVID-19重症患者中升高。术语解释:硫酸乙酰肝素(HS)是一种糖胺聚糖,负责结合多种蛋白质;共受体(co-receptor)指辅助主受体完成信号传递的分子。
The protein encoded by this gene is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The syndecans mediate cell binding, cell signaling, and cytoskeletal organization and syndecan receptors are required for internalization of the HIV-1 tat protein. The syndecan-1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. Altered syndecan-1 expression has been detected in several different tumor types. While several transcript variants may exist for this gene, the full-length natures of only two have been described to date. These two represent the major variants of this gene and encode the same protein. [provided by RefSeq, Jul 2008]
由该基因编码的蛋白质是一种跨膜(I型)硫酸乙酰肝素蛋白多糖,并且是聚糖蛋白聚糖家族中的一员。所述syndecans介导的细胞结合,细胞信号传导和细胞骨架组织和聚糖受体所需的HIV-1的Tat蛋白的内化。该多配体聚糖-1蛋白作为完整的膜蛋白,并通过其细胞外基质蛋白受体参与细胞增殖,细胞迁移和细胞 - 基质相互作用。改变聚糖-1的表达已经在几个不同的肿瘤类型被检测到。而几个转录变异体可能存在于该基因,只有两个全长性质已经描述到日期。这两个代表该基因的主要变体和编码相同蛋白。 [由RefSeq的,2008年7月提供]
SDC1基因(以及对应的蛋白质)的细胞分布位置:
SDC1基因的本体(GO)信息:
名称 |
---|
4512 ECM-receptor interaction [PATH:hsa04512] |
4514 Cell adhesion molecules (CAMs) [PATH:hsa04514] |
5205 Proteoglycans in cancer [PATH:hsa05205] |
5144 Malaria [PATH:hsa05144] |
名称 |
---|
A tetrasaccharide linker sequence is required for GAG synthesis |
Chondroitin sulfate/dermatan sulfate metabolism |
Chylomicron-mediated lipid transport |
Defective B3GAT3 causes JDSSDHD |
Defective B4GALT7 causes EDS, progeroid type |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS |
Defective EXT2 causes exostoses 2 |
Disease |
Diseases associated with glycosaminoglycan metabolism |
Diseases of glycosylation |
Extracellular matrix organization |
Glycosaminoglycan metabolism |
Heparan sulfate/heparin (HS-GAG) metabolism |
HS-GAG biosynthesis |
HS-GAG degradation |
Lipid digestion, mobilization, and transport |
Lipoprotein metabolism |
Metabolism of carbohydrates |
Metabolism of lipids and lipoproteins |
Non-integrin membrane-ECM interactions |
Retinoid metabolism and transport |
Syndecan interactions |
Visual phototransduction |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Obesity | 0.080271442 | 2 | 0 | BeFree_RGD |
Hyperlipidemia | 0.08 | 1 | 0 | RGD |
Myocardial Infarction | 0.08 | 1 | 0 | RGD |
Proteinuria | 0.08 | 1 | 0 | RGD |
Inflammation | 0.08 | 1 | 0 | RGD |
Multiple Myeloma | 0.030411421 | 102 | 0 | BeFree_LHGDN |
Mammary Neoplasms | 0.011168843 | 5 | 0 | BeFree_LHGDN |
Neoplasm Metastasis | 0.005981653 | 12 | 0 | BeFree_LHGDN |
Squamous cell carcinoma | 0.005167327 | 9 | 0 | BeFree_LHGDN |
Breast Carcinoma | 0.004614512 | 17 | 0 | BeFree |
关注微信订阅号,实时查看信息,关注医学生物学动态。